Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States

The human papillomavirus (HPV) vaccine prevents six types of cancer. Previously, this vaccine was only approved for 9–26-year-olds. However, in October 2018 the U.S. Food and Drug Administration approved the HPV vaccine for 27- to 45-year-olds (mid-adults). The current study aimed to assess HPV vacc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Preventive medicine 2024-05, Vol.182, p.107951-107951, Article 107951
Hauptverfasser:	Akpan, Idara N., Taskin, Tanjila, Wheldon, Christopher W., Rossheim, Matthew E., Thompson, Erika L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer prevention Human papillomavirus Mid-adults Shared clinical decision-making Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!